aminocaproic acid has been researched along with Cerebral Palsy in 2 studies
Aminocaproic Acid: An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.
6-aminohexanoic acid : An epsilon-amino acid comprising hexanoic acid carrying an amino substituent at position C-6. Used to control postoperative bleeding, and to treat overdose effects of the thrombolytic agents streptokinase and tissue plasminogen activator.
Cerebral Palsy: A heterogeneous group of nonprogressive motor disorders caused by chronic brain injuries that originate in the prenatal period, perinatal period, or first few years of life. The four major subtypes are spastic, athetoid, ataxic, and mixed cerebral palsy, with spastic forms being the most common. The motor disorder may range from difficulties with fine motor control to severe spasticity (see MUSCLE SPASTICITY) in all limbs. Spastic diplegia (Little disease) is the most common subtype, and is characterized by spasticity that is more prominent in the legs than in the arms. Pathologically, this condition may be associated with LEUKOMALACIA, PERIVENTRICULAR. (From Dev Med Child Neurol 1998 Aug;40(8):520-7)
| Excerpt | Relevance | Reference |
|---|---|---|
| "ε-Aminocaproic acid (EACA) is an antifibrinolytic agent that has been shown to decrease blood loss and transfusion requirements in several populations undergoing various surgical procedures." | 2.94 | Effect of Intravenous Aminocaproid Acid on Blood Loss and Transfusion Requirements After Bilateral Varus Rotational Osteotomy: A Double-blind, Placebo-controlled Randomized Trial. ( Dodwell, E; Edmonds, C; Nguyen, J; Scher, D; Swarup, I, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Swarup, I | 1 |
| Nguyen, J | 1 |
| Edmonds, C | 1 |
| Dodwell, E | 1 |
| Scher, D | 1 |
| Dhawale, AA | 1 |
| Shah, SA | 1 |
| Sponseller, PD | 1 |
| Bastrom, T | 1 |
| Neiss, G | 1 |
| Yorgova, P | 1 |
| Newton, PO | 1 |
| Yaszay, B | 1 |
| Abel, MF | 1 |
| Shufflebarger, H | 1 |
| Gabos, PG | 1 |
| Dabney, KW | 1 |
| Miller, F | 1 |
1 trial available for aminocaproic acid and Cerebral Palsy
| Article | Year |
|---|---|
Effect of Intravenous Aminocaproid Acid on Blood Loss and Transfusion Requirements After Bilateral Varus Rotational Osteotomy: A Double-blind, Placebo-controlled Randomized Trial.
Topics: Administration, Intravenous; Adolescent; Aminocaproic Acid; Antifibrinolytic Agents; Blood Loss, Sur | 2020 |
1 other study available for aminocaproic acid and Cerebral Palsy
| Article | Year |
|---|---|
Are antifibrinolytics helpful in decreasing blood loss and transfusions during spinal fusion surgery in children with cerebral palsy scoliosis?
Topics: Adolescent; Aminocaproic Acid; Analysis of Variance; Antifibrinolytic Agents; Blood Loss, Surgical; | 2012 |